Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

SULFAMERAZINE (2—SULFANILAMIDO-4—METHYLPYRIMIDINE)

III. THE COMPARATIVE ACTIVITY OF SULFAMERAZINE, SULFADIAZINE AND SULFAPYRIDINE IN THE PRODUCTION OF HEMOLYTIC ANEMIA IN THE MOUSE

ALBERT R. LATVEN and ARNOLD D. WELCH
Journal of Pharmacology and Experimental Therapeutics July 1944, 81 (3) 301-306;
ALBERT R. LATVEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARNOLD D. WELCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

III. THE COMPARATIVE ACTIVITY OF SULFAMERAZINE, SULFADIAZINE AND SULFAPYRIDINE IN THE PRODUCTION OF HEMOLYTIC ANEMIA IN THE MOUSE

Abstract

The hemolytic anemia-producing properties of sulfapyridine, sulfamerazine and sulfadiazine have been evaluated in mice by determining the percentage incidence of anemia produced by various concentrations of sulfonamide in the blood. The concentration of sulfonamide in the blood necessary to produce a 50 per cent incidence of anemia was found to be: with sulfapyridine, 2.8 mgm., with sulfadiazine, 33.0 mgm., and with sulfamerazine, 31.0 mgm. per 100 cc. Although a high micromolar concentration of sulfonamide within the erythrocytes was required to produce anemia with sulfadiazine and sulfamerazine, sulfapyridine produced the same incidence of anemia with an erythrocytic concentration only about one-tenth as great. The possible clinical significance of these findings is discussed.

Footnotes

    • Received May 22, 1944.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 81, Issue 3
1 Jul 1944
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
SULFAMERAZINE (2—SULFANILAMIDO-4—METHYLPYRIMIDINE)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

SULFAMERAZINE (2—SULFANILAMIDO-4—METHYLPYRIMIDINE)

ALBERT R. LATVEN and ARNOLD D. WELCH
Journal of Pharmacology and Experimental Therapeutics July 1, 1944, 81 (3) 301-306;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

SULFAMERAZINE (2—SULFANILAMIDO-4—METHYLPYRIMIDINE)

ALBERT R. LATVEN and ARNOLD D. WELCH
Journal of Pharmacology and Experimental Therapeutics July 1, 1944, 81 (3) 301-306;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Meeting Report for the ASPET–Ray Fuller Symposium: Cellular Mechanisms and Novel Strategies for Pain Control
  • Antinociceptive Properties of Fenfluramine, a Serotonin Reuptake Inhibitor, in a Rat Model of Neuropathy
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics